Johnson & Johnson’s (NYSE: JNJ) stock chart is sending a clear signal that contrasts sharply with the persistent hum of repetitive negative headlines. While news cycles continue to circle long-running legal battles, the company’s market performance paints a picture of investor confidence, with its stock climbing over 23% year-to-date.
This growing disconnect suggests a deeper, more fundamental story is unfolding for the healthcare sector giant. Beneath the surface, the strategic separation of its consumer health division has forged a new, more agile Johnson & Johnson.
